Investment
Features
FeesSafety
Academy
More
Pluang+

Compare PepsiCo, Inc. (PEP) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

PepsiCo, Inc.Trade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

PepsiCo, Inc. vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? PepsiCo, Inc. trades at $132.92 (market cap $176.16B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.98 (market cap $10.61B). The key difference: PepsiCo, Inc. is far larger — about 16.6× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and PepsiCo, Inc. pays the higher dividend (4.58%). Which is the better fit depends on your goals — on Pluang, investors hold PepsiCo, Inc. for 108 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

PEPRDY
Market Cap
$176.16B$10.61B
Volume
9,536,0183,738,869
Sector
Consumer StaplesHealth
52-Week High
$170.44$15.38
52-Week Low
$123.64$11.38
Typical Hold Time
108 Days0 Days
Enterprise Value
$216.88B$10.51B
Dividend Yield
4.58%0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

PepsiCo, Inc.

PepsiCo (PEP) trades at $127.28, up 0.44% with consistent earnings beats in recent quarters. The stock shows bearish technical signals but maintains strong fundamentals with 54.17% gross margins and 52.28% ROE. Recent news highlights price adjustments on snack products and sponsorship withdrawals, while analysts project a $142.38 price target with 67.4% holding neutral positions.

PEP offers stable dividend income and operational cash flow strength, though near-term technical weakness and competitive pricing pressures present risks. The company's valuation at 16.26 P/E appears reasonable given its market leadership, but investors should monitor North American performance trends and margin sustainability.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PEP
9% Buy91% Sell
Avg holding period · 108 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About PepsiCo, Inc.

PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.

Read more on PEP →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →